Health
Coronavirus vaccine by AstraZeneca begins late-stage US study – 7NEWS.com.au
The company enlisted by Australia as its primary hope for a vaccine has announced a promising step.
AstraZeneca has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate.
Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said on Monday.
Should the trials prove successful, Australians may be in line to receive the AstraZeneca vaccine.
The trial is being conducted under the US governments Operation Warp Speed program.
The program aims to acc…
-
Business6 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business13 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News8 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
General15 hours agoChris Bowen’s 200 tonne carbon footprint nightmare